Skip to main content

Table 1 CD4 count at HIV care enrollment among men receiving MMT vs two comparators not receiving MMT

From: Retrospective analysis of antiretroviral therapy uptake and retention of male clients receiving methadone maintenance therapy in two provinces in Vietnam: potential synergy of the two therapies

  Number Median age (IQR) Median CD4 count at care enrollment (IQR), cells/mm3 p value
Males receiving MMT 28 34 (31–38) 230 (57–308) 0.541
Males whose injection drug use status was documented and not receiving MMT 237 34 (30–38) 158 (50–370)  
Males receiving MMT 28 34 (31–38) 230 (57–308) 0.308
Males not receiving MMT 633 34(29–37) 143 (35–366)  
Females (not self-reporting injection drug use) 306 31 (30–38) 273 (108–444)  
  1. Females were not included in the analysis, since very few females reported injection drug use. Mann-Whitney test was used to compare the values between those receiving and not receiving MMT